Volume 13, Issue 4 (Vol.13 No.4 Jan 2025)                   rbmb.net 2025, 13(4): 516-524 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Alhayali H, Hojati Z. Possible Association of Glutathione S-Transferase Pi 1 (GSTP1) Gene Polymorphism in Iraqi Patients with Breast Cancer. rbmb.net 2025; 13 (4) :516-524
URL: http://rbmb.net/article-1-1542-en.html
Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Sciences and Technology, University of Isfahan, Iran.
Abstract:   (241 Views)
Background: Investigating the role of glutathione S-transferase pi 1 (GSTP1) in breast cancer development and exploring genetic variations in GSTP1 that may contribute to susceptibility to the disease.

Methods: Blood samples were collected from 40 healthy control individuals and 75 breast cancer patients for genomic DNA extraction. PCR and bioinformatics analysis were used to examine the GSTP1 gene sequences.

Results: Gel electrophoresis confirmed the presence of a 433-bp amplified genetic locus with a 212C>A variation in the intron-4 region, identified as rs757152293. The Single nucleotide polymorphisms (SNP) exhibited variable distributions, with homozygous CC and heterozygous CA genotypes. Patient samples with the CA genotype were submitted to NCBI under accession numbers OL957029-OL957036, while those with the CC genotype were submitted under accession numbers OL957027-OL957034. Additionally, sequence analysis of the rs757152293 SNP in healthy individuals was submitted to NCBI under accession numbers OL957037-OL957041.

Conclusion: This study is the first to suggest a possible association between GSTP1 genetic polymorphism and breast cancer in the investigated population.
Full-Text [PDF 225 kb]   (73 Downloads)    
Type of Article: Original Article | Subject: Molecular Biology
Received: 2024/12/27 | Accepted: 2025/02/16 | Published: 2025/07/30

References
1. Musa Sultan M, Hussein Abdullah T, Abbas Abdullah M, Al-Darkazali W, Sattar Harbi N. Evaluate the Serum of Irisin, Omentin-1, and Oxidative Status in Males with Prostatic Cancer. Rep Biochem Mol Biol. 2024;13(1):23-30. [DOI:10.61186/rbmb.13.1.23] [PMID] []
2. Ahmadzadeh A, Khodayar MJ, Salehcheh M, Nazari Khorasgani Z, Matin M. Evaluation of the Total Oxidant Status to the Antioxidant Capacity Ratio as a Valuable Biomarker in Breast Cancer Patients. Rep Biochem Mol Biol. 2023;12(2):277-283. [DOI:10.61186/rbmb.12.2.277] [PMID] []
3. Ng EH, Gao F, Ji CY, Ho GH, Soo KC. Risk factors for breast carcinoma in Singaporean Chinese women: the role of central obesity. Cancer. 1997;80(4):725-31. https://doi.org/10.1002/(SICI)1097-0142(19970815)80:4<725::AID-CNCR11>3.0.CO;2-V [DOI:10.1002/(SICI)1097-0142(19970815)80:43.0.CO;2-V]
4. Gallegos-Arreola MP, Figuera-Villanueva LE, Ramos-Silva A, Salas-González E, Puebla-Pérez AM, Peralta-Leal V, et al. The association between the 844ins68 polymorphism in the CBS gene and breast cancer. Arch Med Sci. 2014;10(6):1214-24. [DOI:10.5114/aoms.2014.47830] [PMID] []
5. de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, Oosterwijk JC, Kleibeuker JH, et al. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet. 2002;39(4):225-42. [DOI:10.1136/jmg.39.4.225] [PMID] []
6. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999;8(10):843-54.
7. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51-88. [DOI:10.1146/annurev.pharmtox.45.120403.095857] [PMID]
8. Atkinson HJ, Babbitt PC. Glutathione transferases are structural and functional outliers in the thioredoxin fold. Biochemistry. 2009;48(46):11108-16. [DOI:10.1021/bi901180v] [PMID] []
9. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, et al. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev. 2001;10(3):229-36.
10. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272(15):10004-12. [DOI:10.1074/jbc.272.15.10004] [PMID]
11. Xue CX, He XM, Zou DH. Glutathione S-transferase M1 Polymorphism and Breast Cancer Risk: a Meta-Analysis in the Chinese Population. Clin Lab. 2016;62(11):2277-2284. [DOI:10.7754/Clin.Lab.2016.160333] [PMID]
12. Kuang M, Xu W, Cao CX, Shen LL, Chang J, Zhang XL, et al. Glutathione S-transferase P1 rs1695 A>G polymorphism and breast cancer risk: evidence from a meta-analysis. Genet Mol Res. 2016;15(2). [DOI:10.4238/gmr.15027771]
13. Song Z, Shao C, Feng C, Lu Y, Gao Y, Dong C. Association of glutathione S-transferase T1, M1, and P1 polymorphisms in the breast cancer risk: a meta-analysis. Ther Clin Risk Manag. 2016;12:763-9. [DOI:10.2147/TCRM.S104339] [PMID] []
14. Tang J, Zhou Q, Zhao F, Wei F, Bai J, Xie Y, Huang Y. Association of glutathione S-transferase T1, M1 and P1 polymorphisms in the breast cancer risk: a meta-analysis in Asian population. Int J Clin Exp Med. 2015;8(8):12430-47.
15. Xiao ZS, Li Y, Guan YL, Li JG. GSTT1 polymorphism and breast cancer risk in the Chinese population: an updated meta-analysis and review. Int J Clin Exp Med. 2015;8(5):6650-7.
16. Nasr AS, Sami RM, Ibrahim NY, Darwish DO. Glutathione S transferase (GSTP 1, GSTM 1, and GSTT 1) gene polymorphisms in Egyptian patients with acute myeloid leukemia. Indian J Cancer. 2015;52(4):490-5. [DOI:10.4103/0019-509X.178408] [PMID]
17. Gulyan IS, Bystritskaya EP, Chernysheva NY, Eliseeva EV, Apanasevich VI, Isaeva MP. Deletion polymorphism of glutathione S-transferases genes (GSTT1, GSTM1) in patients with breast cancer in Primorye region. Tumors female reproduct sys. 2020;16(3):25-31. [DOI:10.17650/1994-4098-2020-16-3-25-31]
18. Li S, Lang GT, Zhang YZ, Yu KD, Shao ZM, Zhang Q. Interaction between glutathione S-transferase M1-null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer. Cancer Med. 2018;7(9):4202-4207. [DOI:10.1002/cam4.1567] [PMID] []
19. Hashemi M, Eskandari-Nasab E, Fazaeli A, Taheri M, Rezaei H, Mashhadi M, et al. Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population. Biomark Med. 2012;6(6):797-803. [DOI:10.2217/bmm.12.61] [PMID]
20. Sharma A, Pandey A, Sharma S, Chatterjee I, Mehrotra R, Sehgal A, Sharma JK. Genetic polymorphism of glutathione S-transferase P1 (GSTP1) in Delhi population and comparison with other global populations. Meta Gene. 2014;2:134-42. [DOI:10.1016/j.mgene.2013.12.003] [PMID] []
21. Farmohammadi A, Arab-Yarmohammadi V, Ramzanpour R. Association analysis of rs1695 and rs1138272 variations in GSTP1 gene and breast cancer susceptibility. Asian Pac J Cancer Prev. 2020;21(4):1167-1172. [DOI:10.31557/APJCP.2020.21.4.1167] [PMID] []
22. Sergentanis TN, Economopoulos KP. GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;121(1):195-202. [DOI:10.1007/s10549-009-0520-0] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2015 All Rights Reserved | Reports of Biochemistry and Molecular Biology

Designed & Developed by : Yektaweb